表紙
市場調查報告書

腎臟疾病生物標記的市場 - 生物標記的各類型 (腎功能生物標記,京都控制蛋白質等)、各檢驗手法、各終端用戶、各地區:市場規模、佔有率、未來展望、機會分析

Renal Biomarkers Market, By Biomarker Type (Functional Biomarker, Up-Regulated Proteins, Others), By Technique, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 927675
出版日期 內容資訊 英文 164 Pages
商品交期: 2-3個工作天內
價格
腎臟疾病生物標記的市場 - 生物標記的各類型 (腎功能生物標記,京都控制蛋白質等)、各檢驗手法、各終端用戶、各地區:市場規模、佔有率、未來展望、機會分析 Renal Biomarkers Market, By Biomarker Type (Functional Biomarker, Up-Regulated Proteins, Others), By Technique, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年02月27日內容資訊: 英文 164 Pages
簡介

本報告提供全球腎臟疾病生物標記的市場相關分析,診斷技術概要,及市場基本結構及促進、阻礙因素,整體市場規模預測 (過去3年、今後9年份),生物標記的各類型、各檢驗手法、各終端用戶、各地區的詳細趨勢,主要企業的簡介、業績、策略計劃等調查。

第1章 分析目的、前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
    • 影響度分析
  • 近幾年主要的動向
  • 法規方案
  • PEST分析

第4章 全球腎臟疾病生物標記市場:生物標記的各類型

  • 簡介
  • 市場佔有率:各類型 (最新值、預測值)
  • 與前一年同期相比成長率 (YoY):各類型 (總計11年份)
  • 各市場區隔詳細趨勢
    • 腎功能生物標記
      • 簡介
      • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準,總計12年份)
      • 各市場區隔趨勢
      • 血清肌酸
      • 血清胱抑素 C
      • 尿中白蛋白
    • 京都控制蛋白質
      • 嗜中性白血球明膠相關性脂質運載蛋白
      • KIM-1 (腎臟損傷分子)
      • 白細胞介素18
    • 其他

第5章 全球腎臟疾病生物標記市場:各檢驗手法

  • 各市場區隔詳細趨勢
    • ELISA (酵素免疫分析法)
    • PETIA (粒子增強免疫比濁法)
    • 比色分析法
    • CLEIA (化學冷光酵素免疫分析法)
    • 液體層析法-質譜分析

第6章 全球腎臟疾病生物標記市場:各終端用戶

  • 各市場區隔詳細趨勢
    • 診斷測試室
    • 門診病人診所
    • 研究中心
    • 醫院

第7章 全球腎臟疾病生物標記市場:各地區

  • 各地區的詳細趨勢
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 東南亞國協
      • 澳洲
      • 韓國
      • 其他
    • 南美
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他
    • 中東
      • 波灣合作理事會 (GCC) 各國
      • 以色列
      • 其他
    • 非洲
      • 北非
      • 中非
      • 南非

第8章 競爭環境

  • Beckman Coulter, Inc.
    • 公司概要
    • 產品系列
    • 近幾年的主要趨勢
    • 財務成果
    • 策略
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • BIOPORTO A/S
  • Astute Medical, Inc.
  • Randox Laboratories Ltd.
  • SphingoTec GmbH

第9章 附錄

目錄

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. For this purpose various diagnostic tests are performed which involve use of various tests which asses biomarkers to understand functioning of the kidneys. Increase or decrease in values of these biomarkers indicates dysfunction of kidneys.

Restraints of the Global Renal Biomarkers Market

Factors such as low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.

Key features of the study:

  • This report provides in-depth analysis of the global renal biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global renal biomarkers market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global renal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Renal Biomarkers Market, By Biomarker Type:
    • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
    • Up-Regulated Proteins
  • Neutrophil gelatinase-associated lipocalin
  • Kidney injury molecule 1
  • Interleukin 18
    • Others
  • Global Renal Biomarkers Market, By Technique:
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • Global Renal Biomarkers Market, By End User:
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • Global Renal Biomarkers Market, By Geography:
    • North America
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Biomarker Type
    • Functional Biomarker
      • Serum Creatinine
      • Serum Cystatin C
      • Urine Albumin
    • Up-Regulated Proteins
      • Neutrophil gelatinase-associated lipocalin
      • Kidney injury molecule 1
      • Interleukin 18
    • Others
  • By Technique
    • Enzyme Linked Immunosorbent Assay
    • Particle-Enhanced Turbidimetric Immunoassay
    • Colorimetric Assay
    • Chemiluminescent Enzyme Immunoassay
    • Liquid Chromatography-Mass Spectrometry
  • By End User
    • Diagnostic Labs
    • Outpatient Clinics
    • Research Centers
    • Hospitals
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Beckman Coulter, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • BIOPORTO A/S
    • Astute Medical, Inc.
    • Randox Laboratories Ltd.
    • SphingoTec GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Biomarker Type
  • Market Snippet, By Technique
  • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Renal Biomarkers Market, By Biomarker Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Functional Biomarker
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Serum Creatinine
    • Serum Cystatin C
    • Urine Albumin
    • Up-Regulated Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Neutrophil gelatinase-associated lipocalin
    • Kidney injury molecule 1
    • Interleukin 18
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Renal Biomarkers Market, By Technique, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Enzyme Linked Immunosorbent Assay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Particle-Enhanced Turbidimetric Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Colorimetric Assay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Chemiluminescent Enzyme Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Liquid Chromatography-Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Renal Biomarkers Market, By End User, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Diagnostic Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Outpatient Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Research Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Renal Biomarkers Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Beckman Coulter, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BIOPORTO A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astute Medical, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Randox Laboratories Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SphingoTec GmbH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact